Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: AVRA Medical Robotics, Inc.

Market Cap 704M 607M 559M 524M 985M 66.58B 995M 6.61B 2.58B 32.6B 2.64B 2.59B 113B P/E Ratio 2026 *
-58.7x
P/E Ratio 2027 * -58.7x
Enterprise Value 704M 607M 559M 524M 985M 66.58B 995M 6.61B 2.58B 32.6B 2.64B 2.59B 113B EV / Sales 2026 *
11.9x
EV / Sales 2027 * 9.37x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
Change 5-day change 1-year change 3-year change Capi.($)
-3.50%-.--% - - 51.19M
+1.15%+1.11%-11.68%-11.77% 43.58B
+4.02%+7.79%+294.33%+536.67% 34.03B
-1.69%-2.89%+13.70%-17.71% 29.77B
+1.41%-0.96%-0.53%+33.41% 29.82B
+1.16%+9.79%+14.27%+22.28% 25.42B
+2.40%+8.49% - - 13.87B
+0.03%+2.10%+56.75%+111.91% 13.35B
-0.19%-2.62%+3.33%+2.89% 12.85B
+0.93%+0.57%+107.81%+77.40% 12.22B
Average +0.58%+1.88%+59.75%+94.39% 23.88B
Weighted average by Cap. +1.17%+1.86%+61.58%+105.75%

Financials

2026 *2027 *
Net sales 59.4M 51.2M 47.12M 44.2M 83.03M 5.61B 83.86M 557M 218M 2.75B 223M 218M 9.51B 75.2M 64.81M 59.65M 55.96M 105M 7.11B 106M 705M 275M 3.48B 282M 276M 12.04B
Net income -12M -10.34M -9.52M -8.93M -16.77M -1.13B -16.94M -113M -43.96M -555M -45.03M -44.08M -1.92B -14M -12.07M -11.11M -10.42M -19.57M -1.32B -19.77M -131M -51.28M -648M -52.54M -51.42M -2.24B
Net Debt - -
Logo AVRA Medical Robotics, Inc.
SS Innovations International, Inc., formerly AVRA Medical Robotics, Inc, is a medical robotics company. The Company is engaged in developing a fully autonomous medical robotic system using its software, which integrates artificial intelligence (AI) and deep learning, or machine learning (DL). By using an AI and DL-enhanced software program, it is creating an intelligent robotic system that robotizes a range of medical procedures. It is developing a treatment-independent autonomous robotics system utilizing its AI-driven precision guidance system, applicable to a variety of minimally and non-invasive procedures, with a focus on skin resurfacing aesthetic procedures. Its medical robotic system is being developed to deliver skin resurfacing treatments, such as micro-needling and laser therapies. Its autonomous medical robotics system is being developed to be compatible with available surgical tools and end-effectors, enabling it to enter the micro-needling and laser solutions market.
Employees
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!